A groundbreaking genetic test developed by researchers at Mass General Brigham Heart and Vascular Institute can estimate an individual's risk for eight major heart-related conditions through a single DNA analysis. This test utilizes a polygenic risk score (PRS) that integrates data from hundreds of thousands of common genetic variants, enabling early identification of cardiovascular risks before symptoms manifest. The study, published in the Journal of the American College of Cardiology (JACC), analyzed data from over 245,000 participants and revealed that individuals with high genetic risk scores had significantly elevated odds of developing diseases compared to those with average scores. For instance, those in the top 10% for high lipoprotein(a) levels had over a 40-times higher chance of abnormal levels than average-risk individuals. The test focuses on conditions such as coronary artery disease, atrial fibrillation, and type 2 diabetes, among others. By identifying risks early, patients can adopt lifestyle changes or medications to mitigate potential health issues, ultimately improving their long-term heart health.